Elizabeth A. Barrett

This profile gathers the share dealings of Elizabeth A. Barrett across 2 companies, led by UroGen Pharma Ltd. and Sage Therapeutics, Inc. Over a trading history stretching from 15 November 2019 to 31 July 2025, the count stands at 31 filings.

Both buying and selling appear: 4 purchases worth €568k, against 3 sales worth €436k. On balance, insiders were net buyers of €132k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants and 21 option exercises.

In size, the median ticket on the buying side is €171k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 4 purchases show a median change of +0.9%, with the price up in 50% of them. This is a record of the past, not a forecast.

The latest filing, published on 31 July 2025, reports a transaction in Sage Therapeutics, Inc. The clock since the last published purchase (15 December 2020) now reads 2,154 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.